Using Real-World Data to Determine Health System Costs of Ontario Women Screened for Breast Cancer.


Journal

Current oncology (Toronto, Ont.)
ISSN: 1718-7729
Titre abrégé: Curr Oncol
Pays: Switzerland
ID NLM: 9502503

Informations de publication

Date de publication:
31 10 2022
Historique:
received: 23 10 2022
revised: 23 10 2022
accepted: 27 10 2022
entrez: 10 11 2022
pubmed: 11 11 2022
medline: 15 11 2022
Statut: epublish

Résumé

Our study was to determine breast cancer screening costs in Ontario, Canada for screenings conducted through a formal (Ontario Breast Screening Program, OBSP) and informal (non-OBSP) screening program using administrative databases. Included women were 49-74 years of age when receiving screening mammograms between 1 January 2013 to 31 December 2019. Each woman was followed for a screening episode with screening and diagnostic components, and costs were calculated as an average cost per woman per month in 2021 Canadian dollars. The final cohort of 1,546,386 women screened had a mean age of 59.4 ± 7.1 years and ~87% were screened via OBSP. The average total cost per woman per month was $136 ± $103, $134 ± $103 and $155 ± $104 for the entire, OBSP and non-OBSP cohorts, respectively. This was further disaggregated into the average total screening cost per month, which was $103 ± $8, $100 ± $4 and $117 ± $9 per woman, and the average total diagnostic cost per woman per month at $219 ± $166, $228 ± $165 and $178 ± $159. for the entire, OBSP and non-OBSP cohorts, respectively. These results indicate similar screening costs across the different cohorts, but higher diagnostic costs for the OBSP cohort.

Identifiants

pubmed: 36354717
pii: curroncol29110657
doi: 10.3390/curroncol29110657
pmc: PMC9689006
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

8330-8339

Subventions

Organisme : CIHR
ID : #155865
Pays : Canada

Références

J Med Screen. 2014 Dec;21(4):180-8
pubmed: 25186116
J Clin Epidemiol. 1992 Jun;45(6):613-9
pubmed: 1607900
Health Rep. 2015 Dec;26(12):16-25
pubmed: 26676235
CMAJ Open. 2018 Feb 8;6(1):E77-E86
pubmed: 29440151
J Natl Cancer Inst. 2014 May 28;106(6):dju092
pubmed: 24872543
J Pers Med. 2021 Jun 04;11(6):
pubmed: 34199804
Ann Intern Med. 2016 Nov 15;165(10):700-712
pubmed: 27548583
Radiology. 2020 Oct;297(1):40-48
pubmed: 32749212
J Natl Cancer Inst. 2020 Apr 1;112(4):400-409
pubmed: 31233138

Auteurs

Nicole Mittmann (N)

Department of Pharmacology & Toxicology, University of Toronto, 1 King's College Circle, Toronto, ON M5S 1A8, Canada.
Sunnybrook Research Institute, Sunnybrook Health Sciences Centre, Toronto, ON M4G 3M5, Canada.

Soo Jin Seung (SJ)

HOPE Research Centre, Sunnybrook Research Institute, 2075 Bayview Avenue, Toronto, ON M4N 3M5, Canada.

Christina Diong (C)

ICES Central, 2075 Bayview Avenue, Toronto, ON M4N 3M5, Canada.

Jodi M Gatley (JM)

ICES Central, 2075 Bayview Avenue, Toronto, ON M4N 3M5, Canada.

Michael Wolfson (M)

School of Epidemiology and Public Health, University of Ottawa, 600 Peter Morand Crescent, Ottawa, ON K1G 5Z3, Canada.

Marie-Hélène Guertin (MH)

Institut National De Santé Publique Du Québec, 945, av Wolfe, Quebec City, QC G1V 5B3, Canada.

Nora Pashayan (N)

Department of Applied Health Research, University College London, 1-19 Torrington Place, London WC1E 7Hb, UK.

Jacques Simard (J)

CHU de Québec-Université Laval Research Center, 2705 Boul Laurier, Quebec City, QC G1V 4G2, Canada.

Anna M Chiarelli (AM)

Ontario Health, 525 University Avenue, Toronto, ON M5G 2L3, Canada.
Dalla Lana School of Public Health, University of Toronto, 155 College Street, Toronto, ON M5T 3M7, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH